<DOC>
	<DOC>NCT01301066</DOC>
	<brief_summary>A 12-Week, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study.</brief_summary>
	<brief_title>A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>Males and females (nonpregnant, nonlactating females) 1870 years of age, inclusive, at time of consent. Both men and women of child bearing potential (i.e., not surgically sterile or postmenopausal defined as age &gt;40 years without menses for â‰¥2 years) must agree to use at least 2 reliable forms of contraception Documented HIV infection. Homozygous familial hypercholesterolemia Any conditions that may cause secondary dyslipidemia History of coronary artery disease (CAD) or CAD equivalent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>